• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Arrowhead Research Corp. (ARWR)

    -NasdaqGS
    7.53 Down 0.21(2.71%) Feb 27, 4:00PM EST
    |After Hours : 7.53 Down 0.00 (0.01%) Feb 27, 4:38PM EST
    Add to Portfolio
    Prev Close:7.74
    Open:7.73
    Bid:N/A
    Ask:11.00 x 600
    1y Target Est:14.50
    Beta:2.97
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:7.44 - 7.75
    52wk Range:4.95 - 27.63
    Volume:1,000,928
    Avg Vol (3m):2,416,020
    Market Cap:412.58M
    P/E (ttm):N/A
    EPS (ttm):-1.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARWRDown 2.71%412.58M
    PENCUp 11.11%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,404.28
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Sep-15) :-1.54
    Quarterly EPS Est (Mar-15) :-0.39
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):-0.69

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arrowhead Research Corporation develops novel drugs to treat intractable diseases in the United States. The company’s principal product candidates comprise ARC-520, an RNAi-based therapeutic that is in Phase IIa clinical trial to treat chroni... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback